請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23791
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳瑞華(Ruey-Hwa Chen) | |
dc.contributor.author | Hsiang-Ching Chung | en |
dc.contributor.author | 鍾向晴 | zh_TW |
dc.date.accessioned | 2021-06-08T05:10:09Z | - |
dc.date.copyright | 2011-07-29 | |
dc.date.issued | 2011 | |
dc.date.submitted | 2011-07-17 | |
dc.identifier.citation | Akaogi, K., et al. (2009). 'KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha.' Oncogene 28(32): 2894-2902.
Arany, Z., et al. (1996). 'An essential role for p300/CBP in the cellular response to hypoxia.' Proc Natl Acad Sci U S A 93(23): 12969-12973. Arany, Z., et al. (1995). 'A family of transcriptional adaptor proteins targeted by the E1A oncoprotein.' Nature 374(6517): 81-84. Asangani, I. A., et al. (2008). 'MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.' Oncogene 27(15): 2128-2136. Bommer, G. T., et al. (2007). 'p53-mediated activation of miRNA34 candidate tumor-suppressor genes.' Curr Biol 17(15): 1298-1307. Bruce, S. J., et al. (2007). 'Dynamic transcription programs during ES cell differentiation towards mesoderm in serum versus serum-freeBMP4 culture.' BMC Genomics 8: 365. Bruick, R. K. and S. L. McKnight (2001). 'A conserved family of prolyl-4-hydroxylases that modify HIF.' Science 294(5545): 1337-1340. Calin, G. A., et al. (2004). 'MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.' Proc Natl Acad Sci U S A 101(32): 11755-11760. Calin, G. A., et al. (2004). 'Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.' Proc Natl Acad Sci U S A 101(9): 2999-3004. Chambers, A. F., et al. (1995). 'Steps in tumor metastasis: new concepts from intravital videomicroscopy.' Cancer Metastasis Rev 14(4): 279-301. Chang, T. C., et al. (2007). 'Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.' Mol Cell 26(5): 745-752. Chiambaretta, F., et al. (2004). 'Cell and tissue specific expression of human Kruppel-like transcription factors in human ocular surface.' Mol Vis 10: 901-909. Chiosea, S., et al. (2007). 'Overexpression of Dicer in precursor lesions of lung adenocarcinoma.' Cancer Res 67(5): 2345-2350. Cho, Y. G., et al. (2007). 'Genetic and epigenetic analysis of the KLF4 gene in gastric cancer.' APMIS 115(7): 802-808. Choi, B. J., et al. (2006). 'Altered expression of the KLF4 in colorectal cancers.' Pathol Res Pract 202(8): 585-589. Cimmino, A., et al. (2005). 'miR-15 and miR-16 induce apoptosis by targeting BCL2.' Proc Natl Acad Sci U S A 102(39): 13944-13949. Claffey, K. P., et al. (1996). 'Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.' Cancer Res 56(1): 172-181. Dang, D. T., et al. (2000). 'Decreased expression of the gut-enriched Kruppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients.' FEBS Lett 476(3): 203-207. Debbas, M. and E. White (1993). 'Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.' Genes Dev 7(4): 546-554. Denko, N. C., et al. (2003). 'Investigating hypoxic tumor physiology through gene expression patterns.' Oncogene 22(37): 5907-5914. Dews, M., et al. (2006). 'Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.' Nat Genet 38(9): 1060-1065. Di Renzo, M. F., et al. (1992). 'Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.' Oncogene 7(12): 2549-2553. Didiano, D. and O. Hobert (2006). 'Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions.' Nat Struct Mol Biol 13(9): 849-851. Djuranovic, S., et al. (2011). 'A parsimonious model for gene regulation by miRNAs.' Science 331(6017): 550-553. Duffy, M. J., et al. (1999). 'Urokinase plasminogen activator: a prognostic marker in multiple types of cancer.' J Surg Oncol 71(2): 130-135. Ehlermann, J., et al. (2003). 'Dynamic expression of Kruppel-like factor 4 (Klf4), a target of transcription factor AP-2alpha during murine mid-embryogenesis.' Anat Rec A Discov Mol Cell Evol Biol 273(2): 677-680. Epstein, A. C., et al. (2001). 'C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.' Cell 107(1): 43-54. Esteban, M. A., et al. (2006). 'Regulation of E-cadherin expression by VHL and hypoxia-inducible factor.' Cancer Res 66(7): 3567-3575. Fidler, I. J. (2003). 'The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.' Nat Rev Cancer 3(6): 453-458. Foster, K. W., et al. (2000). 'Increase of GKLF messenger RNA and protein expression during progression of breast cancer.' Cancer Res 60(22): 6488-6495. Foster, K. W., et al. (2005). 'Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia.' Oncogene 24(9): 1491-1500. Foster, K. W., et al. (1999). 'Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF.' Cell Growth Differ 10(6): 423-434. Freedman, S. J., et al. (2002). 'Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha.' Proc Natl Acad Sci U S A 99(8): 5367-5372. Garrett-Sinha, L. A., et al. (1996). 'A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells.' J Biol Chem 271(49): 31384-31390. Geiman, D. E., et al. (2000). 'Transactivation and growth suppression by the gut-enriched Kruppel-like factor (Kruppel-like factor 4) are dependent on acidic amino acid residues and protein-protein interaction.' Nucleic Acids Res 28(5): 1106-1113. Ghaleb, A. M., et al. (2011). 'Altered intestinal epithelial homeostasis in mice with intestine-specific deletion of the Kruppel-like factor 4 gene.' Dev Biol 349(2): 310-320. Ghaleb, A. M., et al. (2007). 'Haploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.' Cancer Res 67(15): 7147-7154. Giraldez, A. J., et al. (2006). 'Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs.' Science 312(5770): 75-79. Gottardo, F., et al. (2007). 'Micro-RNA profiling in kidney and bladder cancers.' Urol Oncol 25(5): 387-392. Graham, C. H., et al. (1999). 'Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression.' Int J Cancer 80(4): 617-623. Grimson, A., et al. (2007). 'MicroRNA targeting specificity in mammals: determinants beyond seed pairing.' Mol Cell 27(1): 91-105. Guo, Y., et al. (2008). 'Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma.' Cancer Res 68(1): 26-33. Hanahan, D. and R. A. Weinberg (2000). 'The hallmarks of cancer.' Cell 100(1): 57-70. Hanahan, D. and R. A. Weinberg (2011). 'Hallmarks of cancer: the next generation.' Cell 144(5): 646-674. He, L. and G. J. Hannon (2004). 'MicroRNAs: small RNAs with a big role in gene regulation.' Nat Rev Genet 5(7): 522-531. Huang, L. E. and H. F. Bunn (2003). 'Hypoxia-inducible factor and its biomedical relevance.' J Biol Chem 278(22): 19575-19578. Hutvagner, G., et al. (2001). 'A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA.' Science 293(5531): 834-838. Ide, T., et al. (2006). 'Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.' Int J Cancer 119(12): 2750-2759. Imai, T., et al. (2003). 'Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells.' Am J Pathol 163(4): 1437-1447. Ivan, M., et al. (2001). 'HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.' Science 292(5516): 464-468. Jaakkola, P., et al. (2001). 'Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.' Science 292(5516): 468-472. Jaubert, J., et al. (2003). 'Ectopic expression of kruppel like factor 4 (Klf4) accelerates formation of the epidermal permeability barrier.' Development 130(12): 2767-2777. Jeffers, M., et al. (1998). 'The mutationally activated Met receptor mediates motility and metastasis.' Proc Natl Acad Sci U S A 95(24): 14417-14422. Kaluz, S., et al. (2008). 'Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element.' Clin Chim Acta 395(1-2): 6-13. Karube, Y., et al. (2005). 'Reduced expression of Dicer associated with poor prognosis in lung cancer patients.' Cancer Sci 96(2): 111-115. Katz, J. P., et al. (2005). 'Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach.' Gastroenterology 128(4): 935-945. Keblusek, P., et al. (1999). 'The adenoviral E1A oncoproteins interfere with the growth-inhibiting effect of the cdk-inhibitor p21(CIP1/WAF1).' J Gen Virol 80 ( Pt 2): 381-390. Krishnamachary, B., et al. (2003). 'Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.' Cancer Res 63(5): 1138-1143. Kulshreshtha, R., et al. (2007). 'A microRNA signature of hypoxia.' Mol Cell Biol 27(5): 1859-1867. Kumar, M. S., et al. (2007). 'Impaired microRNA processing enhances cellular transformation and tumorigenesis.' Nat Genet 39(5): 673-677. Kuo, J. C., et al. (2006). 'The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway.' J Cell Biol 172(4): 619-631. Kurrey, N. K., et al. (2005). 'Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level.' Gynecol Oncol 97(1): 155-165. Lagos-Quintana, M., et al. (2003). 'New microRNAs from mouse and human.' RNA 9(2): 175-179. Lando, D., et al. (2002). 'Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch.' Science 295(5556): 858-861. Lee, T. H., et al. (2003). 'Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability.' J Biol Chem 278(7): 5277-5284. Lee, Y., et al. (2003). 'The nuclear RNase III Drosha initiates microRNA processing.' Nature 425(6956): 415-419. Lee, Y., et al. (2004). 'MicroRNA genes are transcribed by RNA polymerase II.' EMBO J 23(20): 4051-4060. Lee, Y. S. and A. Dutta (2009). 'MicroRNAs in cancer.' Annu Rev Pathol 4: 199-227. Lehmann, U., et al. (2008). 'Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.' J Pathol 214(1): 17-24. Lengauer, C., et al. (1998). 'Genetic instabilities in human cancers.' Nature 396(6712): 643-649. Lester, R. D., et al. (2007). 'uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.' J Cell Biol 178(3): 425-436. Lewis, B. P., et al. (2005). 'Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.' Cell 120(1): 15-20. Lewis, B. P., et al. (2003). 'Prediction of mammalian microRNA targets.' Cell 115(7): 787-798. Li, D., et al. (2011). 'KLF4-Mediated Negative Regulation of IFITM3 Expression Plays a Critical Role in Colon Cancer Pathogenesis.' Clin Cancer Res 17(11): 3558-3568. Li, R., et al. (2010). 'A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts.' Cell Stem Cell 7(1): 51-63. Lim, L. P., et al. (2005). 'Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.' Nature 433(7027): 769-773. Liu, C., et al. (1992). 'Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas.' Oncogene 7(1): 181-185. Loffler, D., et al. (2007). 'Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.' Blood 110(4): 1330-1333. Lowe, S. W. and H. E. Ruley (1993). 'Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.' Genes Dev 7(4): 535-545. Lu, J., et al. (2005). 'MicroRNA expression profiles classify human cancers.' Nature 435(7043): 834-838. Lujambio, A., et al. (2007). 'Genetic unmasking of an epigenetically silenced microRNA in human cancer cells.' Cancer Res 67(4): 1424-1429. Lund, E., et al. (2004). 'Nuclear export of microRNA precursors.' Science 303(5654): 95-98. Luo, A., et al. (2004). 'Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray.' Oncogene 23(6): 1291-1299. Maity, A. and D. Solomon (2000). 'Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia.' Exp Cell Res 255(2): 250-257. Martello, G., et al. (2010). 'A MicroRNA targeting dicer for metastasis control.' Cell 141(7): 1195-1207. Maxwell, P. H., et al. (1999). 'The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.' Nature 399(6733): 271-275. McManus, M. T. (2003). 'MicroRNAs and cancer.' Semin Cancer Biol 13(4): 253-258. Meng, F., et al. (2007). 'MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.' Gastroenterology 133(2): 647-658. Nickenig, G., et al. (2002). 'Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo.' FASEB J 16(9): 1077-1086. Pandya, A. Y., et al. (2004). 'Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer.' Clin Cancer Res 10(8): 2709-2719. Panigada, M., et al. (1999). 'GKLF in thymus epithelium as a developmentally regulated element of thymocyte-stroma cross-talk.' Mech Dev 81(1-2): 103-113. Patel, N. V., et al. (2010). 'Expression of the tumor suppressor Kruppel-like factor 4 as a prognostic predictor for colon cancer.' Cancer Epidemiol Biomarkers Prev 19(10): 2631-2638. Pennacchietti, S., et al. (2003). 'Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.' Cancer Cell 3(4): 347-361. Plate, K. H., et al. (1992). 'Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.' Nature 359(6398): 845-848. Pyke, C., et al. (1991). 'Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.' Am J Pathol 138(5): 1059-1067. Rofstad, E. K., et al. (2005). 'The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.' Cancer Res 65(6): 2387-2396. Rofstad, E. K., et al. (2002). 'Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor.' Cancer Res 62(6): 1847-1853. Roldo, C., et al. (2006). 'MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.' J Clin Oncol 24(29): 4677-4684. Rong, S., et al. (1994). 'Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.' Proc Natl Acad Sci U S A 91(11): 4731-4735. Rowland, B. D., et al. (2005). 'The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene.' Nat Cell Biol 7(11): 1074-1082. Rowland, B. D. and D. S. Peeper (2006). 'KLF4, p21 and context-dependent opposing forces in cancer.' Nat Rev Cancer 6(1): 11-23. Sahlgren, C., et al. (2008). 'Notch signaling mediates hypoxia-induced tumor cell migration and invasion.' Proc Natl Acad Sci U S A 105(17): 6392-6397. Schmitt, M., et al. (1997). 'Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy.' Thromb Haemost 78(1): 285-296. Schuh, R., et al. (1986). 'A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Kruppel, a Drosophila segmentation gene.' Cell 47(6): 1025-1032. Segre, J. A., et al. (1999). 'Klf4 is a transcription factor required for establishing the barrier function of the skin.' Nat Genet 22(4): 356-360. Semenza, G. L. (2010). 'HIF-1: upstream and downstream of cancer metabolism.' Curr Opin Genet Dev 20(1): 51-56. Serrano, M., et al. (1997). 'Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.' Cell 88(5): 593-602. Shie, J. L., et al. (2000). 'Gut-enriched Kruppel-like factor represses cyclin D1 promoter activity through Sp1 motif.' Nucleic Acids Res 28(15): 2969-2976. Shields, J. M., et al. (1996). 'Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest.' J Biol Chem 271(33): 20009-20017. Shields, J. M. and V. W. Yang (1997). 'Two potent nuclear localization signals in the gut-enriched Kruppel-like factor define a subfamily of closely related Kruppel proteins.' J Biol Chem 272(29): 18504-18507. Shields, J. M. and V. W. Yang (1998). 'Identification of the DNA sequence that interacts with the gut-enriched Kruppel-like factor.' Nucleic Acids Res 26(3): 796-802. Shweiki, D., et al. (1992). 'Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.' Nature 359(6398): 843-845. Sullivan, R. and C. H. Graham (2007). 'Hypoxia-driven selection of the metastatic phenotype.' Cancer Metastasis Rev 26(2): 319-331. Swamynathan, S. K., et al. (2007). 'Conditional deletion of the mouse Klf4 gene results in corneal epithelial fragility, stromal edema, and loss of conjunctival goblet cells.' Mol Cell Biol 27(1): 182-194. Tagawa, H. and M. Seto (2005). 'A microRNA cluster as a target of genomic amplification in malignant lymphoma.' Leukemia 19(11): 2013-2016. Takahashi, K. and S. Yamanaka (2006). 'Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.' Cell 126(4): 663-676. Trusolino, L. and P. M. Comoglio (2002). 'Scatter-factor and semaphorin receptors: cell signalling for invasive growth.' Nat Rev Cancer 2(4): 289-300. Volinia, S., et al. (2006). 'A microRNA expression signature of human solid tumors defines cancer gene targets.' Proc Natl Acad Sci U S A 103(7): 2257-2261. Wang, J., et al. (2010). 'Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration.' Cancer Res 70(24): 10182-10191. Wang, N., et al. (2002). 'Down-regulation of gut-enriched Kruppel-like factor expression in esophageal cancer.' World J Gastroenterol 8(6): 966-970. Wei, D., et al. (2005). 'Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression.' Cancer Res 65(7): 2746-2754. Wei, D., et al. (2006). 'Emerging role of KLF4 in human gastrointestinal cancer.' Carcinogenesis 27(1): 23-31. Weis, S., et al. (2004). 'Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis.' J Cell Biol 167(2): 223-229. Wenger, R. H., et al. (2005). 'Integration of oxygen signaling at the consensus HRE.' Sci STKE 2005(306): re12. Xu, J., et al. (2008). 'Dynamic down-regulation of Kruppel-like factor 4 in colorectal adenoma-carcinoma sequence.' J Cancer Res Clin Oncol 134(8): 891-898. Yet, S. F., et al. (1998). 'Human EZF, a Kruppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains.' J Biol Chem 273(2): 1026-1031. Yoon, H. S., et al. (2003). 'Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage.' J Biol Chem 278(4): 2101-2105. Yoon, H. S., et al. (2005). 'Kruppel-like factor 4 prevents centrosome amplification following gamma-irradiation-induced DNA damage.' Oncogene 24(25): 4017-4025. Yoon, H. S. and V. W. Yang (2004). 'Requirement of Kruppel-like factor 4 in preventing entry into mitosis following DNA damage.' J Biol Chem 279(6): 5035-5041. Yoon, S. Y., et al. (2006). 'uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line.' Cell Res 16(1): 75-81. Yori, J. L., et al. (2010). 'Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression.' J Biol Chem 285(22): 16854-16863. Yu, F., et al. (2011). 'Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion.' Oncogene 30(18): 2161-2172. Zhang, P., et al. (2010). 'Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression.' J Biol Chem 285(12): 9180-9189. Zhang, W., et al. (2000). 'The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.' J Biol Chem 275(24): 18391-18398. Zhang, W., et al. (1998). 'The gut-enriched Kruppel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion.' J Biol Chem 273(28): 17917-17925. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23791 | - |
dc.description.abstract | 低氧常見於固體型腫瘤,是一個對細胞或組織氧氣供給不正常的現象。當腫瘤細胞處於低氧情況時, 常引起各種反應以因應此狀況,例如血管新生或腫瘤轉移,而調控這些低氧反應最主要的因子是缺氧誘導因子–1 (HIF-1)。近年來,微型核醣核酸 (microRNA) 被發現能受低氧狀況所誘導而增加表現量,例如 miR-103/107 就是其中之一。然而這些微型核醣核酸受低氧誘導表現量增加的機制以及生物功能並不清楚。在本論文中,我們主要探討受低氧誘導表現量增加的 miR-103/107 在細胞移動所扮演的角色。透過冷光酵素活性的測定,我們發現缺氧誘導因子–1 能直接調控 miR-103-1 與 miR-107 的啟動子。除此之外,我們也證實了 miR-103/107 能促進細胞移動。更重要的是,利用 miRNA 海綿 (miRNA sponge) 抑制 miR-103/107 的功能,能阻礙受低氧誘導增加表現之 miR-103/107 促進細胞移動的能力,顯示被缺氧誘導因子–1 引起表現的 miR-103/107 能調控細胞受低氧所促進的移動能力。為了解 miR-103/107 是如何影響細胞移動,我們搜尋了具有抑制細胞移動能力之 miR-103/107 的標靶基因。透過生物信息學預測以及文獻回顧,我們聚焦於 KLF4,它被報導是一個腫瘤抑制因子且具有抑制細胞移動的能力。我們透過實驗證實在多株細胞中, miR-103/107 能標靶 KLF4 信使 RNA (mRNA) 的 3 端非編碼區 (3’-UTR) 而抑制內生性 KLF4 蛋白。此外,KLF4 的表現受低氧狀況所抑制,而這個抑制的現象能被反義之 miR-103/107 (anti-miR-103/107) 恢復,暗示了 miR-103/107 在低氧情況下抑制 KLF4 的重要性。有趣的是,當過度表現 KLF4 能抑制 miR-103/107 所促進的細胞移動能力,而剔除 KLF4 則能恢復低氧狀況下 miR-103/107 海綿所抑制的細胞移動能力。這些結果支持了我們提出的概念: miR-103/107 能藉由抑制 KLF4 以促進細胞移動能力。總結來說,我們發現在低氧狀況下,缺氧誘導因子–1 能引起 miR-103/107 表現,而此時 miR-103/107 能透過 KLF4 去促進細胞移動能力。這個新的路徑代表了其中一個低氧促進細胞移動的機制,而且可能參與了癌化的過程。 | zh_TW |
dc.description.abstract | Hypoxia, a phenomena of abnormally decreased oxygen supply to cells or tissues, is commonly seen in solid tumors. During hypoxia, tumor cells elicit variety of cellular responses such as angiogenesis and metastasis to compromise the hypoxic condition, and the key factor in these processes is hypoxia-inducible factor 1 (HIF-1). Recent studies have shown that miR-103/107 are upregulated by hypoxia. However, the molecular mechanism underlying their upregulation and the biological functions of these miRNAs in hypoxia are still unknown. In this study, we focus on the role of hypoxia-inducible miR-103/107 in cell migration. First, using luciferase activity assay and ChIP assay, we demonstrated a direct regulation of the promoters of miR-103-1 and miR-107 by HIF-1α. We further showed that miR-103/107 promoted cell migration. More importantly, blockage of the action of miR-103/107 by miR-103/107-specific sponge inhibited hypoxia-induced cell migration. These data indicate that HIF-1α-induced miR-103/107 expression participates in hypoxia-induced cell migration. Next, we searched for miR-103/107 targets that mediate the inhibition of migration. Through bioinformatic prediction and literature review, we focused on KLF4, a known tumor suppressor gene involved in the inhibition of cell migration. Experimental validation substantiated that miR-103/107 targeted 3′-UTR of KLF4 to downregulate the endogenous KLF4 expression in multiple cells lines. Moreover, hypoxia-induced KLF4 downregulation was rescued by anti-miR-103/107, indicating an important role of miR-103/107 in KLF4 downregulation in hypoxia. Interestingly, overexpression of KLF4 attenuated miR-103/107-induced cell migration, and shRNA-based downregulation of KLF4 restored the inhibitory effect of miR-103/107 sponge on cell migration during hypoxia. These results support the notion that miR-103/107 promotes cell migration by targeting KLF4. In conclusion, we identify a novel pathway through which HIF-1α-induced miR-103/107 target KLF4 to potentiate cell migration. This pathway represents one mechanism underlying hypoxia-induced motility of tumor cells and may participate in tumor progression. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T05:10:09Z (GMT). No. of bitstreams: 1 ntu-100-R98b46013-1.pdf: 1330009 bytes, checksum: 5b0ba4418660510c95188cab7cec7fe2 (MD5) Previous issue date: 2011 | en |
dc.description.tableofcontents | 摘要 ..................................................................................................................................i
Abstract ...........................................................................................................................ii Introduction ....................................................................................................................3 1. Tumor progression ...................................................................................................3 1.1. The role of hypoxia in tumor progression ..................................................3 1.2. The role of hypoxia in metastasis ...............................................................4 2. Activation of HIF pathway during hypoxia .............................................................7 3. MicroRNA ...............................................................................................................9 3.1. Biogenesis of microRNA ............................................................................9 3.2. MicroRNA targeting .................................................................................11 3.3. MicroRNA expression in cancer ...............................................................12 3.4. The role of microRNA in tumor progression ............................................13 4. Kruppel-like factor 4 (KLF4) ................................................................................13 4.1. Overview of KLF4 ....................................................................................14 4.2. Functions of KLF4 ....................................................................................14 4.3. KLF4 as a tumor suppressor .....................................................................16 4.4.KLF4 act as an oncoprotein in a context-dependent manner ....................17 Preface ...........................................................................................................................19 Material and Methods ..................................................................................................20 Plasmids ................................................................................................................20 Antibodies and reagents ........................................................................................21 Cell culture and transient transfection ..................................................................21 Lentivirus production and infection ......................................................................21 Luciferase assay ....................................................................................................22 MiRNA quantification ...........................................................................................23 ChIP-qPCR assay ..................................................................................................24 Migration assay .....................................................................................................24 MicroRNA target prediction tools .........................................................................25 Results ............................................................................................................................26 Hypoxia induces the expression of miR-103-1 and miR-107 but not miR-103-2 in HCT116 cells .........................................................................................................26 HIF-1α regulates the expression of miR-103-1 and miR-107 during hypoxia ..........27 HIF-1α directly binds to HREs on the promoters of miR-103-1 and miR-107 ..........28 Induction of miR-103/107 contributes in part to hypoxia-induced cell migration ....28 MiR-103/107 target prediction ..................................................................................30 The KLF4 3′-UTR is a target of miR-103/107 ..........................................................31 MiR-103/107 downregulates KLF4 through a KLF4 3′-UTR-specific mechanism ..31 KLF4 attenuates miR-103/107-enhanced cell migration ...........................................32 Anti-miR-103/107 rescues hypoxia-induced KLF4 downregulation ........................33 The miR-103/107 sponge-mediated cell motility inhibition is partially rescued by KLF4 depletion .....................................................................................................33 Discussion ......................................................................................................................35 References ......................................................................................................................40 Figures ...........................................................................................................................51 Table ...............................................................................................................................63 | |
dc.language.iso | en | |
dc.title | 探討低氧誘導之 miR-103/107 藉由 KLF4 對細胞移動之影響 | zh_TW |
dc.title | The hypoxia-induced miR-103/107 targets KLF4 to regulate cell migration | en |
dc.type | Thesis | |
dc.date.schoolyear | 99-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 鄒安平(Ann-Ping Tsou),鄧述諄(Shu-Chun Teng) | |
dc.subject.keyword | 微型核醣核酸,KLF4, | zh_TW |
dc.subject.keyword | microRNA,KLF4, | en |
dc.relation.page | 78 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2011-07-18 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生化科學研究所 | zh_TW |
顯示於系所單位: | 生化科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-100-1.pdf 目前未授權公開取用 | 1.3 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。